CCR7

There are 65 papers on CCR7 in aging research: 7 trials and 41 observational studies in people, 11 in animals, 3 in cells, 2 reviews. The newest story, Nov 2, 2026: “Immune cell group elevated before cancer in people with HIV”.

Gene

65 papers study it6 findings

HGNCNCBI GeneTaxon

See all 65 papers on CCR7

At a glance

The findings reach people, from one lab or study. 6 independent labs in 3 countries.

“Interestingly, the high CCR7 expression on BLCA cell membranes was a prognostic protective factor.”
Chemokine receptor 7 contributes to T- and B-cell filtering in ageing bladder, cystitis and bladder cancerImmunity & ageing : I & A2024doi:10.1186/s12979-024-00432-5

None of its findings points the other way.

Cells, mice and humans: a single group. Worms or flies: nothing yet.
  • 6 independent labs in 3 countries
  • Funders: Bundesministerium für Forschung, Technologie und Raumfahrt and others
  • Human trial7
  • Humans41
  • Animals11
  • Cells3
  • In silico1

Interventions

2

Yeast-derived nanoparticles

upin mice1

1 study
  1. Yeast-derived nanoparticles increase CCR7 in mice after immunization.

    Animalsafter immunizationgut

More on Yeast-derived nanoparticles

Procyanidin B2

downin human cells1

1 study
  1. Procyanidin B2 decreases CCR7 in Pg. LPS-stimulated PDLSCs.

    Cellsin Pg. LPS-stimulated PDLSCs

More on Procyanidin B2

Effects

3

Cellular senescence

upin human cells1

1 study
  1. CCR7 increases cellular senescence in human cells (Ang II-induced in VSMCs).

    CellsAng II-induced in VSMCs

More on Cellular senescence

Glymphatic influx

upin mice1

1 study
  1. CCR7 improves glymphatic influx in mice (shown by hematopoietic CCR7 deficiency).

    Animalsshown by hematopoietic CCR7 deficiencybrain

Central nervous system lymphoma

is required forin mice1

1 study
  1. CCR7 is required for central nervous system lymphoma in mice (CCR7 deletion from lymphoma cells).

    AnimalsCCR7 deletion from lymphoma cellsbrain

More on Central nervous system lymphoma

Associations

1

Favorable prognosis

upin humans1

1 study
  1. CCR7 predicts favorable prognosis in humans (bladder urothelial carcinoma).

    Humansbladder urothelial carcinomabladder urothelial carcinoma cell membrane

Funding

1 grant since 2020

National Institute of Allergy and Infectious Diseases$1.9M

Latest

Dec 2025: 2Jan 2026: 0Feb 2026: 3Mar 2026: 0Apr 2026: 2May 2026: 0Jun 2026: 0Jul 2026: 1Aug 2026: 2Sep 2026: 0Oct 2026: 0Nov 2026: 010 papers in 12 months
Journal of Immunology

Immune cell group elevated before cancer in people with HIV

Within one immune cell type, the share carrying a surface protein was a median 21.4% before cancer in people with HIV, versus 11.7% without HIV.Within one immune cell type, the share carrying a surface protein was a median 21.4% before cancer in people with HIV, versus 11.7% without HIV.

Cohort studyImmune response

See all 65 papers on CCR7